Mineralys Therapeutics, Inc. (MLYS)

Healthcare · Biotechnology · NASDAQ

Mineralys Therapeutics, Inc. (MLYS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.41B and a free-cash-flow yield of -7.7%.

Market cap	$2.41B
Trailing P/E	—
FCF yield	-7.7%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live MLYS data on Nama Insights →